NewGLab Pharma Co Ltd
KOSDAQ:214870
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its Industry Average (16.5), the stock would be worth ₩-2 482 032.22 (35 993% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -0 | ₩6 915 |
0%
|
| Industry Average | 16.5 | ₩-2 482 032.22 |
-35 993%
|
| Country Average | 15.1 | ₩-2 265 631.98 |
-32 864%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| KR |
N
|
NewGLab Pharma Co Ltd
KOSDAQ:214870
|
439.9m KRW | -0 | -0.1 | |
| JP |
|
Keyence Corp
TSE:6861
|
18.5T JPY | 46.1 | 41.7 | |
| US |
|
Keysight Technologies Inc
NYSE:KEYS
|
60.1B USD | 48.4 | 62.5 | |
| CN |
|
Hangzhou Hikvision Digital Technology Co Ltd
SZSE:002415
|
332.6B CNY | 16.2 | 22.3 | |
| US |
|
Teledyne Technologies Inc
NYSE:TDY
|
29.9B USD | 52 | 32.1 | |
| SE |
|
Hexagon AB
STO:HEXA B
|
266.4B SEK | 27.7 | 12.2 | |
| TW |
|
Chroma ATE Inc
TWSE:2360
|
898B TWD | 370.1 | 76.8 | |
| CN |
|
Zhonghang Electronic Measuring Instruments Co Ltd
SZSE:300114
|
192.9B CNY | -1 591.8 | 1 890.2 | |
| UK |
|
Halma PLC
LSE:HLMA
|
16.7B GBP | 47.1 | 48 | |
| CN |
|
Huagong Tech Co Ltd
SZSE:000988
|
120.2B CNY | -430.2 | 81.7 | |
| US |
|
Trimble Inc
NASDAQ:TRMB
|
15.9B USD | 54.1 | 37.4 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 8.1 |
| Median | 15.1 |
| 70th Percentile | 28.4 |
| Max | 21 200 |
Other Multiples
NewGLab Pharma Co Ltd
Glance View
NewGLAB Pharma Co., Ltd. engages in the manufacture of closed-circuit television camera and equipment. The company is headquartered in Bucheon, Gyeonggi-Do. The company went IPO on 2015-10-13. The firm's product portfolio consists of general analog cameras that used for CCTVs, high definition (HD) analog cameras, HD-serial digital interface (SDI) cameras, extend (EX)-SDI cameras, internet protocol (IP) cameras that used for network CCTVs, digital video recorders (DVRs) that used for image storage devices, network video recorders (NVRs) and others. In addition, the Company is involved in the business of 5G smartphone distribution. The firm distributes its products within domestic market and to overseas markets.
